BIOS Health raises €1.2M Growth round

25 July 2022· Cambridge, United Kingdom· health, precision_medicine, ai, neurotechnology, b2b, software_hardware

This funding is to extend Canadian AI collaboration on neuro-cardiology, building upon existing collaborative work to develop an AI-controlled closed-loop neuromodulation system for chronic cardiac conditions, and to take the research right up to the point of clinical trials in humans.

Investors

LeadMEDTEQ+

Also participating

Ministry of Economy and Innovation of QuebecMitacs AccelerateHealthy BrainsHealthy Lives program at McGill University

About BIOS Health

Stage

Series A

Headquarters

Cambridge, United Kingdom

Founded

2015

Team Size

21–50

Sectors

healthprecision_medicineaineurotechnologyb2bsoftware_hardware

https://www.bios.health

Source: https://www.bios.health/news/ca18m-ai-neuro-cardiology-funding